MedPath

Investigation of availability of chemical shift MRI in a nodule shadow doubting pulmonary hamartoma or benign pulmonary tumor in chest CT

Not Applicable
Conditions
Pulmonary hamartoma
Registration Number
JPRN-UMIN000027127
Lead Sponsor
Clinical Research Support Center Kyushu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
109
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with apparent complication of suspicious primary or metastatic pulmonary tumors from imaging diagnosis and progress. 2) Patients with metastatic pulmonary tumor as primary lesion of 1:renal cell carcinoma, 2:hepatic cell carcinoma and 3:liposarcoma (because fat component is included in tumor) and without passed 5 year after occurrence of primary lesion. 3) Any other patients who are regarded as unsuitable for the study by the investigators. 4) Patients who can't medically and mentally have MRI examination 5) Patients who refuse the participation in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath